Ovarian Cancer Immunotherapy
199,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
100 °P sammeln
  • Gebundenes Buch

Ovarian Cancer Immunotherapy provides a broad overview of several aspects of basic sciences, and clinical and therapeutic aspects of immunotherapy for ovarian cancer, as well as state-of-the-art information on molecular genetics and biology. Chapters are written by a team of expert contributors from around the world and explore topics such as antibody therapeutics for ovarian carcinoma, emerging serum biomarkers, ovarian cancer immunity, adoptive cell immunotherapy, the biology of dendritic cells, the role of growth factors, and more.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Ovarian Cancer Immunotherapy provides a broad overview of several aspects of basic sciences, and clinical and therapeutic aspects of immunotherapy for ovarian cancer, as well as state-of-the-art information on molecular genetics and biology. Chapters are written by a team of expert contributors from around the world and explore topics such as antibody therapeutics for ovarian carcinoma, emerging serum biomarkers, ovarian cancer immunity, adoptive cell immunotherapy, the biology of dendritic cells, the role of growth factors, and more.
Autorenporträt
Samir A. Farghaly, MD, PhD is a Professor Obstetrics and Gynecology at the Joan and Sanford I. Weill Medical College, Graduate School of Medical Sciences; Sandra and Edward Meyer Cancer Center; and New York-Presbyterian Hospital/Weill Cornell Medical Center in New York, NY. He received his MD and PhD in molecular biology from London University. Dr. Farghaly is the Founder and Editor-in Chief of Current Trends in Gynecologic Oncology, and The International Journal of Gynecological, Obstetrical, and Reproductive Medicine Research. He is a member of the editorial boards of 18 international medical journals on Gynecological Cancers, Gene Expression and Therapy, Women's Health, and Gynecology.